rifaprim and Lung-Diseases

rifaprim has been researched along with Lung-Diseases* in 1 studies

Other Studies

1 other study(ies) available for rifaprim and Lung-Diseases

Article	Year
[Use of rifamethoprim in acute and chronic respiratory tract diseases]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:1 Rifamethoprim is a new formulation containing rifampicin and trimethoprim. Its efficacy was studied in the treatment of a group of patients with various nonspecific diseases of the lungs. It was shown to be highly active against a broad spectrum of pathogens. With inclusion of trimethoprim to the formulation it appeared possible to markedly lower the bacterial ability to develop resistance to rifampicin, which solved the problem of long-term antibiotic use. The unique pharmacokinetic properties of rifampicin such as its capacity to penetrating into the sputum, lung tissues and cells make rifamethoprim be the drug of optimal choice in the treatment of respiratory diseases. Topics: Acute Disease; Anti-Bacterial Agents; Bronchial Diseases; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Humans; Lung Diseases; Rifampin; Trimethoprim	1992

Article

Year

[Use of rifamethoprim in acute and chronic respiratory tract diseases].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:1

Rifamethoprim is a new formulation containing rifampicin and trimethoprim. Its efficacy was studied in the treatment of a group of patients with various nonspecific diseases of the lungs. It was shown to be highly active against a broad spectrum of pathogens. With inclusion of trimethoprim to the formulation it appeared possible to markedly lower the bacterial ability to develop resistance to rifampicin, which solved the problem of long-term antibiotic use. The unique pharmacokinetic properties of rifampicin such as its capacity to penetrating into the sputum, lung tissues and cells make rifamethoprim be the drug of optimal choice in the treatment of respiratory diseases.

Topics: Acute Disease; Anti-Bacterial Agents; Bronchial Diseases; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Humans; Lung Diseases; Rifampin; Trimethoprim

1992